DexCom: Revenue Up, EPS Misses Mark

[cafead]

via

• Revenue for Q4 2024 was $1.114 billion, marking an 8% increase year-over-year.
• Non-GAAP EPS stood at $0.45, missing the estimated $0.50 and reflecting a 10% decline from Q4 2023.
• Operating income (non-GAAP) decreased to $209.5 million from $242.7 million.

article source